AVEO Pharmaceuticals, Inc. [NASDAQ:AVEO]: Analyst Rating and Earnings

Equities traders oftentimes stay updated on what leading stock market analysts say about a potential stock purchase. When it comes to AVEO Pharmaceuticals, Inc. [AVEO], the most recently available average analyst rating is from the quarter that ends in December. On average, stock market experts give AVEO an Hold rating. Its stock price has been found in the range of 0.49 to 3.59. This is compared to its latest closing price of $0.71.

Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for AVEO Pharmaceuticals, Inc. [AVEO] is sitting at 2.80. This is compared to 1 month ago, when its average rating was 2.80.

Keep looking out for the next-scheduled quarterly financial results that this company is expected to put out, which is slated to occur on Tue 6 Aug (In 78 Days).

Fundamental Analysis of AVEO Pharmaceuticals, Inc. [AVEO]

Now let’s turn to look at profitability: with a current Operating Margin for AVEO Pharmaceuticals, Inc. [AVEO] sitting at -481.12, this company’s Net Margin is now 70.30%. These measurements indicate that AVEO Pharmaceuticals, Inc. [AVEO] is generating considerably more profit, after expenses are accounted for, compared to its market peers.

Similarly, its Total Debt to Total Assets stands at 68.13.

What about valuation? This company’s Enterprise Value to EBITDA is -4.18. The Enterprise Value to Sales for this firm is now 18.14, and its Total Debt to Enterprise Value stands at 0.09.

Shifting the focus to workforce efficiency, AVEO Pharmaceuticals, Inc. [AVEO] earns $318,176 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 3.16 and its Total Asset Turnover is 0.14. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 1.54 and its Current Ratio is 1.54. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

AVEO Pharmaceuticals, Inc. [AVEO] has 169.86M shares outstanding, amounting to a total market cap of $120.60M. Its stock price has been found in the range of 0.49 to 3.59. At its current price, it has moved by -80.96% from its 52-week high, and it has moved 39.30% from its 52-week low.

This stock’s Beta value is currently 1.33, which indicates that it is more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 38.36. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is AVEO Pharmaceuticals, Inc. [AVEO] a Reliable Buy?

Shares of AVEO Pharmaceuticals, Inc. [AVEO], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.